Views of Wall Street’s Leading Experts on Warrior Met Coal Inc

With 1.12 million shares changed hands, the volume of the stock remained heavier than its average volume of 0.85 million shares. During the session, the Coking Coal company that operates in wider Basic Materials sector, reached to the highest price of $62.62 whereas the lowest price it dropped to was $60.59. The 52-week range on HCC shows that it touched its highest point at $69.36 and its lowest point at $31.69 during that stretch. It currently has a 1-year price target of $69.67. With its current market cap of 3.17 billion, HCC has annualized dividend of $0.29 while the current yield stands at 0.48%. Beta for the stock currently stands at 1.10.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.

Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!

Get the FREE Report with all the details here.


Price Performance and Earnings:

Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of HCC was up-trending over the past week, with a rise of 7.47%, but this was up by 7.30% over a month. Three-month performance dropped to -1.68% while six-month performance rose 20.40%. The stock gained 69.40% in the past year, while it has gained 0.44% so far this year. A look at the trailing 12-month EPS for HCC yields 9.20 with Next year EPS estimates of 6.61. For the next quarter, that number is 2.57. This implies an EPS growth rate of -15.78% for this year and -18.20% for next year.

Float and Shares Shorts:

At present, 52.02 million HCC shares are outstanding with a float of 51.38 million shares on hand for trading. On Mar 15, 2024, short shares totaled 3.66 million, which was 7.00% higher than short shares on Feb 15, 2024. In addition to HCA as the firm’s HCA Healthcare, Inc., CC serves as its Chemours Company (The).

Institutional Ownership:

Through their ownership of 95.25% of HCC’s outstanding shares, institutional investors have majority control over the company.

Analysts Ratings:

Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for HCC since 0 analysts follow the stock currently. In the same way, a target price assigned to a stock can also reveal much about its potential.